Oklo 10-Qquarter ended 2026-03-31

Executive Summary

Oklo remains pre-commercial: Q1 2026 produced no operating revenue, while spending accelerated on its first Aurora powerhouse, fuel infrastructure, and isotope businesses. The operating loss widened to $51.2M, but a $1.18B net equity raise lifted cash and marketable securities to $2.54B, giving the company substantial resources to pursue development. DOE authorizations and customer agreements advance the opportunity, but they do not resolve the decisive uncertainties: nuclear licensing, first-of-a-kind construction, fuel supply, and conversion of prospective customers into priced, binding power contracts. For investors, the near-term case rests on whether that capital buys measurable progress toward the targeted 2028 first deployment without disproportionate cost growth or dilution.

Key Financial Highlights

• Expense drivers: R&D rose to $27.0M from $7.85M; general and administrative expense rose to $24.2M from $10.0M. Hiring, engineering, professional services and stock-based compensation drove the increases.
• Earnings quality: Net interest and dividend income rose to $21.3M from $3.65M as invested financing proceeds grew. Stock-based compensation increased to $15.6M from $2.31M, contributing to the gap between net loss and operating cash use.
• Capital deployment: Cash property, plant and equipment purchases rose to $32.8M from $0.332M; another $20.7M of purchases remained in payables and accruals. Net property, plant and equipment reached $95.6M from $42.3M at year-end, showing development moving into the asset base.
• Funding and dilution: The completed at-the-market offering provided $1.18B of net proceeds. Shares outstanding increased 13.4M, or 8.3%, during Q1 to 173.9M; the stronger balance sheet came with substantial shareholder dilution.

Business Developments

Oklo’s stated strategy is to build, own and operate Aurora powerhouses and sell electricity and heat, rather than sell reactor designs. That offers potential recurring revenue but makes Oklo responsible for construction, operating, fuel and financing costs. Its first Idaho National Laboratory powerhouse is targeted for 2028. DOE approved a nuclear safety design agreement and authorized the project to proceed under its Reactor Pilot Program; site preparation continues with Kiewit Nuclear Solutions selected as lead constructor. Those steps advance the project but are not a commercial operating license.

Customer interest includes a 12-gigawatt master power agreement with Switch and a January 2026 Meta prepayment agreement to advance a planned 1.2-gigawatt Ohio campus. Other prospective arrangements include non-binding letters of intent. Converting interest into priced, binding power purchase agreements is the commercial test. A separate $25.0M customer rights payment remains a liability and would be credited through future pricing discounts.

Oklo is also allocating capital to fuel fabrication and recycling, intended both to support its reactors and to address constrained fuel supply. Its Tennessee recycling-facility roadmap contemplates up to $1.68B of investment, subject to development and approvals. In isotopes, the Atomic Alchemy acquisition added two development programs; Oklo’s Idaho radiochemistry laboratory received a materials license, while planned products and facilities still face distinct permitting or construction requirements.

Risk Assessment

• Licensing and schedule: The NRC denied Oklo’s initial custom combined-license application without prejudice in 2022; an updated application and subsequent approvals are essential to the targeted 2028 deployment.
• First-of-a-kind execution: Idaho construction, enhanced testing and reliance on specialized contractors could raise costs or delay the first powerhouse; expected cost reductions on later units remain unproven.
• Fuel availability and cost: Constrained high-assay low-enriched uranium supply, inflation and trade restrictions could increase spending or delay projects despite DOE fuel support and Oklo’s fabrication initiatives.
• Pre-commercial economics: No operating revenue yet offsets expanding expenses; management projects $80M–$100M of cash used in operating expenses and $350M–$450M of investing cash use in FY 2026.
• Customer conversion: Master agreements and letters of intent do not establish final power pricing or guarantee sales; the $25.0M rights liability also represents a potential future pricing concession.
• Investment valuation: $17.1M of private-company investments have limited liquidity and depend on observable transactions or impairment assessments for valuation adjustments.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: FY2025 10-K.

Strategic Outlook and Investor Actionables

The enlarged cash position gives Oklo room to pursue its first reactor and adjacent fuel and isotope businesses. The investment thesis now depends less on access to immediate funding than on turning regulatory progress and customer interest into licensed, buildable projects with credible economics.

• Idaho deployment: Monitor NRC application progress, construction milestones and capital spending against the 2028 target; slippage would weaken the first-powerhouse timeline.
• Commercial conversion: Watch for binding power purchase agreements with defined pricing and delivery terms, rather than additional preliminary capacity announcements.
• Cash use and dilution: Compare operating and investing cash use with FY 2026 guidance, while tracking shares outstanding; accelerating spend without licensing or contract progress would challenge the value of the equity raise.